A small randomized double-blind placebo-controlled trial investigated the effects of alpha-tocopherol supplementation in AP patients, with significant results regarding reduced oxidative stress and inflammation, determined by a significant reduction in MDA, CRP, and IL-6 levels, in parallel with an increased total antioxidant status [29] (Table 1). The gene discussed is CRP; the disease is alkaline phosphatase measurement.